Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"The Lancet. Oncology"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Mok%2C+Tony%22&type=Person&filter%5B%5D=journalStr%3A%22The+Lancet.+Oncology%22
/vufind/Search/Results?lookfor=%22Mok%2C+Tony%22&type=Person&filter%5B%5D=journalStr%3A%22The+Lancet.+Oncology%22
Search /vufind/Search2/Results?lookfor=%22Mok%2C+Tony%22&type=Person&filter%5B%5D=journalStr%3A%22The+Lancet.+Oncology%22
PubPharm (15)
1
Dacomitinib in NSCLC : a positive trial with little clinical impact - Authors' reply
enthalten in:
The Lancet. Oncology
| 2018
von
Wu, Y.
|
Mok, T.
CommentOn: Lancet Oncol. 2017 Nov;18(11):1454-1466. - PMID 28958502
Wird geladen...
2
De-novo and acquired resistance to immune checkpoint targeting
enthalten in:
The Lancet. Oncology
| 2017
von
Syn, N.
|
Teng, M.
|
Mok, T.
| +1
Wird geladen...
3
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050) : a randomised, open-label, phase 3 trial
enthalten in:
The Lancet. Oncology
| 2017
von
Wu, Y.
|
Cheng, Y.
|
Zhou, X.
| +15
CommentIn: Lancet Oncol. 2017 Nov;18(11):1425-1426. - PMID 28958503
Wird geladen...
4
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5) : a randomised, controlled, open-label, phase 3 trial
enthalten in:
The Lancet. Oncology
| 2017
von
Shaw, A.
|
Kim, T.
|
Crinò, L.
| +17
CommentIn: Lancet Oncol. 2017 Jul;18(7):837-839. - PMID 28602777
Wird geladen...
5
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7) : a phase 2B, open-label, randomised controlled trial
enthalten in:
The Lancet. Oncology
| 2016
von
Park, K.
|
Tan, E.
|
O'Byrne, K.
| +20
CommentIn: Lancet Oncol. 2016 May;17(5):541-3. - PMID 27301025
Wird geladen...
6
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS) : a phase 3 randomised trial
enthalten in:
The Lancet. Oncology
| 2015
von
Soria, J.
|
Wu, Y.
|
Nakagawa, K.
| +16
Wird geladen...
7
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations : a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
enthalten in:
The Lancet. Oncology
| 2015
von
Yang, J.
|
Sequist, L.
|
Geater, S.
| +10
CommentIn: Lancet Oncol. 2015 Jul;16(7):746-8. - PMID 26051233
Wird geladen...
8
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6) : analysis of overall survival data from two randomised, phase 3 trials
enthalten in:
The Lancet. Oncology
| 2015
von
Yang, J.
|
Wu, Y.
|
Schuler, M.
| +25
CommentIn: Lancet Oncol. 2015 Feb;16(2):118-9. - PMID 25589190
Wird geladen...
9
Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer : a multicentre, open-label, phase 2 trial
enthalten in:
The Lancet. Oncology
| 2014
von
Jänne, P.
|
Ou, S.
|
Kim, D.
| +11
CommentIn: Nat Rev Clin Oncol. 2015 Jan;12(1):3. - PMID 25421284
Wird geladen...
10
Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009) : a randomised, double-blind, phase 3 trial
enthalten in:
The Lancet. Oncology
| 2014
von
Ramalingam, S.
|
Jänne, P.
|
Mok, T.
| +15
CommentIn: Lancet Oncol. 2014 Nov;15(12):1289-90. - PMID 25439684
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: The Lancet. Oncology
Medienart
15
Aufsätze
15
E-Artikel
15
E-Ressourcen
Zeitschriftentitel
The Lancet. Oncology
Thema
12
Journal Article
8
EC 2.7.10.1
8
Randomized Controlled Trial
8
Research Support, Non-U.S. Gov't
7
Clinical Trial, Phase III
7
EGFR protein, human
7
ErbB Receptors
7
Quinazolines
5
Multicenter Study
5
Protein Kinase Inhibitors
4
5092U85G58
4
Antineoplastic Agents
4
Comparative Study
4
Quinazolinones
4
dacomitinib
3
04Q9AIZ7NO
3
41UD74L59M
3
Afatinib
3
Cisplatin
3
Clinical Trial, Phase II
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
14
2010-2019
1
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
15
Englisch
Haven't found what you're looking for?
Wird geladen...